Serum copper as a novel biomarker for resistance to thyroid hormone

Biochemical Journal

Volumn 443, Issue 1, 2012, Pages 103-109

  Mittag, Jens ^a   Behrends, Thomas ^b   Nordström, Kristina ^a   Anselmo, Joao ^c   Vennström, Björn ^a   Schomburg, Lutz ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c HOSPITAL DO DIVINO ESPÍRITO SANTO   (Portugal)

Author keywords

Copper; Kidney; Liver; Resistance to thyroid hormone (RTH); Thyroid hormone receptor

Indexed keywords

BIOLOGICAL MARKER; CERULOPLASMIN; COPPER; COPPER ZINC SUPEROXIDE DISMUTASE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; LEVOTHYROXINE; MESSENGER RNA; METALLOTHIONEIN I; METALLOTHIONEIN II; SELENIUM; THYROID HORMONE;

ARTICLE; BLOOD SAMPLING; CELL STRAIN HEPG2; CERULOPLASMIN BLOOD LEVEL; CONTROLLED STUDY; COPPER BLOOD LEVEL; DIAGNOSTIC ERROR; GENOTYPE; GRAVES DISEASE; HORMONE BLOOD LEVEL; HUMAN; HUMAN CELL; HYPERTHYROIDISM; HYPOTHYROIDISM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; SCREENING; SIGNAL TRANSDUCTION; THYROID FUNCTION TEST; THYROID HORMONE RESISTANCE; WESTERN BLOTTING; X RAY FLUORESCENCE;

ADOLESCENT; ADULT; ANIMALS; BIOLOGICAL MARKERS; CERULOPLASMIN; CHILD; CHILD, PRESCHOOL; COPPER; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; INFANT; KIDNEY; LIVER; MALE; METALLOTHIONEIN; MICE; MICE, INBRED C57BL; MIDDLE AGED; SELENIUM; SUPEROXIDE DISMUTASE; THYROID HORMONE RESISTANCE SYNDROME; TRIIODOTHYRONINE; YOUNG ADULT;

MUS;

EID: 84858320607     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20111817     Document Type: Article

References (36)

1. Roberts, C. G. and Ladenson, P. W. (2004) Hypothyroidism. Lancet 363, 793-803 (Pubitemid 38315171)
2. Yen, P. M. (2001) Physiological and molecular basis of thyroid hormone action. Physiol. Rev. 81, 1097-1142
3. De Felice, M. and Di Lauro, R. (2004) Thyroid development and its disorders: genetics and molecular mechanisms. Endocr. Rev. 25, 722-746 (Pubitemid 39362295)
4. Cheng, S. Y., Leonard, J. L. and Davis, P. J. (2010) Molecular aspects of thyroid hormone actions. Endocr. Rev. 31, 139-170
5. Weiss, R. E. and Refetoff, S. (2000) Resistance to thyroid hormone. Rev. Endocr. Metab. Disord. 1, 97-108
6. Weiss, R. E., Dumitrescu, A. and Refetoff, S. (2010) Approach to the patient with resistance to thyroid hormone and pregnancy. J. Clin. Endocr. Metab. 95, 3094-3102
7. Beck-Peccoz, P., Persani, L., Mantovani, S., Cortelazzi, D. and Asteria, C. (1996) Thyrotropin-secreting pituitary adenomas. Metab. Clin. Exp. 45, 75-79 (Pubitemid 26281949)
8. Kvistad, P. H. and Myking, O. L. (2001) Hereditary thyroxin-binding globulin deficiency-changed thyroid function tests. Tidsskr Nor Laegeforen. 121, 1336-1338 (Pubitemid 33708411)
9. Reutrakul, S., Sadow, P. M., Pannain, S., Pohlenz, J., Carvalho, G. A., Macchia, P. E., Weiss, R. E. and Refetoff, S. (2000) Search for abnormalities of nuclear corepressors, coactivators, and a coregulator in families with resistance to thyroid hormone without mutations in thyroid hormone receptor β or α genes. J. Clin. Endocr. Metab. 85, 3609-3617
10. Vennstrom, B., Mittag, J. and Wallis, K. (2008) Severe psychomotor and metabolic damages caused by a mutant thyroid hormone receptor α1 in mice: can patients with a similar mutation be found and treated? Acta Paediatr. 97, 1605-1610
11. Mittag, J., Wallis, K. and Vennstrom, B. (2010) Physiological consequences of the TRα1 aporeceptor state. Heart Failure Rev. 15, 111-115
12. Mittag, J., Behrends, T., Hoefig, C. S., Vennstrom, B. and Schomburg, L. (2010) Thyroid hormones regulate selenoprotein expression and selenium status in mice. PLos ONE. 5, e12931
13. Tinnikov, A., Nordstrom, K., Thoren, P., Kindblom, J. M., Malin, S., Rozell, B., Adams, M., Rajanayagam, O., Pettersson, S., Ohlsson, C. et al. (2002) Retardation of post-natal development caused by a negatively acting thyroid hormone receptor α1. EMBO J. 21, 5079-5087
14. Wallis, K., Sjogren, M., van Hogerlinden, M., Silberberg, G., Fisahn, A., Nordstrom, K., Larsson, L., Westerblad, H., Morreale de Escobar, G., Shupliakov, O. and Vennstrom, B. (2008) Locomotor deficiencies and aberrant development of subtype-specific GABAergic interneurons caused by an unliganded thyroid hormone receptor α1. J. Neurosci. 28, 1904-1915 (Pubitemid 351302678)
15. Stosnach, H. (2005) Environmental trace-element analysis using a benchtop total reflection X-ray fluorescence spectrometer. Anal. Sci. 21, 873-876
16. Forrest, D., Erway, L. C., Ng, L., Altschuler, R. and Curran, T. (1996) Thyroid hormone receptor beta is essential for development of auditory function. Nat. Gen. 13, 354-357 (Pubitemid 26230504)
17. Sjogren, M., Alkemade, A., Mittag, J., Nordstrom, K., Katz, A., Rozell, B., Westerblad, H., Arner, A. and Vennstrom, B. (2007) Hypermetabolism in mice caused by the central action of an unliganded thyroid hormone receptor α1. EMBO J. 26, 4535-4545 (Pubitemid 350036638)
18. Anselmo, J., Cao, D., Karrison, T., Weiss, R. E. and Refetoff, S. (2004) Fetal loss associated with excess thyroid hormone exposure. JAMA, J. Am. Med. Assoc. 292, 691-695 (Pubitemid 39062522)
19. Kim, H., Son, H. Y., Bailey, S. M. and Lee, J. (2009) Deletion of hepatic Ctr1 reveals its function in copper acquisition and compensatory mechanisms for copper homeostasis. Am. J. Physiol. Gastrointest. Liver Physiol. 296, G356-G364
20. Massie, H. R., Ofosu-Appiah, W. and Aiello, V. R. (1993) Elevated serum copper is associated with reduced immune response in aging mice. Gerontology 39, 136-145 (Pubitemid 23240975)
21. Merle, U., Tuma, S., Herrmann, T., Muntean, V., Volkmann, M., Gehrke, S. G. and Stremmel, W. (2010) Evidence for a critical role of ceruloplasmin oxidase activity in iron metabolism of Wilson disease gene knockout mice. J. Gastro. Hepatol. 25, 1144-1150
22. Tanaka, A., Kaneto, H., Miyatsuka, T., Yamamoto, K., Yoshiuchi, K., Yamasaki, Y., Shimomura, I., Matsuoka, T. A. and Matsuhisa, M. (2009) Role of copper ion in the pathogenesis of type 2 diabetes. Endocr. J. 56, 699-706
23. Kaplan, J. H. and Lutsenko, S. (2009) Copper transport in mammalian cells: special care for a metal with special needs. J. Biol. Chem. 284, 25461-25465
24. Feng, X., Jiang, Y., Meltzer, P. and Yen, P. M. (2000) Thyroid hormone regulation of hepatic genes in vivo detected by complementary DNA microarray. Mol. Endocrinol. 14, 947-955 (Pubitemid 32250513)
25. Flores-Morales, A., Gullberg, H., Fernandez, L., Stahlberg, N., Lee, N. H., Vennstrom, B. and Norstedt, G. (2002) Patterns of liver gene expression governed by TRβ. Mol. Endocrinol. 16, 1257-1268 (Pubitemid 34621074)
26. Lalioti, V., Muruais, G., Tsuchiya, Y., Pulido, D. and Sandoval, I. V. (2009) Molecular mechanisms of copper homeostasis. Front. Biosci. 14, 4878-4903
27. Turnlund, J. R., Keen, C. L. and Smith, R. G. (1990) Copper status and urinary and salivary copper in young men at three levels of dietary copper. Am. J. Clin. Nutr. 51, 658-664
28. Kehoe, C. A., Turley, E., Bonham, M. P., O'Connor, J. M., McKeown, A., Faughnan, M. S., Coulter, J. S., Gilmore, W. S., Howard, A. N. and Strain, J. J. (2000) Response of putative indices of copper status to copper supplementation in human subjects. Br. J. Nutr. 84, 151-156
29. Fitch, C. A., Song, Y. and Levenson, C. W. (1999) Developmental regulation of hepatic ceruloplasmin mRNA and serum activity by exogenous thyroxine and dexamethasone. Proc. Soc. Exp. Biol.Med. 221, 27-31
30. Zhang, F., Liu, N., Wang, X., Zhu, L. and Chai, Z. (2004) Study of trace elements in blood of thyroid disorder subjects before and after 131I therapy. Biol. Trace Elem. Res. 97, 125-134
31. Mitchell, C. S., Savage, D. B., Dufour, S., Schoenmakers, N., Murgatroyd, P., Befroy, D., Halsall, D., Northcott, S., Raymond-Barker, P., Curran, S. et al. (2010) Resistance to thyroid hormone is associated with raised energy expenditure, muscle mitochondrial uncoupling, and hyperphagia. J. Clin. Invest. 120, 1345-1354
32. Itoh, Y., Esaki, T., Kaneshige, M., Suzuki, H., Cook, M., Sokoloff, L., Cheng, S. Y. and Nunez, J. (2001) Brain glucose utilization in mice with a targeted mutation in the thyroid hormone α or β receptor gene. Proc. Natl. Acad. Sci. U.S.A. 98, 9913-9918 (Pubitemid 32769403)
33. Liu, Y. Y., Schultz, J. J. and Brent, G. A. (2003) A thyroid hormone receptor α gene mutation (P398H) is associated with visceral adiposity and impaired catecholamine-stimulated lipolysis in mice. J. Biol. Chem. 278, 38913-38920 (Pubitemid 37221791)
34. Quignodon, L., Vincent, S., Winter, H., Samarut, J. and Flamant, F. (2007) A point mutation in the activation function 2 domain of thyroid hormone receptor α1 expressed after CRE-mediated recombination partially recapitulates hypothyroidism. Mol. Endocrinol. 21, 2350-2360 (Pubitemid 47529350)
35. Conley, L., Geurs, T. L. and Levin, L. A. (2005) Transcriptional regulation of ceruloplasmin by an IL-6 response element pathway. Brain Res. 139, 235-241 (Pubitemid 41317936)
36. Renko, K., Hofmann, P. J., Stoedter, M., Hollenbach, B., Behrends, T., Kohrle, J., Schweizer, U. and Schomburg, L. (2009) Down-regulation of the hepatic selenoprotein biosynthesis machinery impairs selenium metabolism during the acute phase response in mice. FASEB J. 23, 1758-1765